Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.

The RH5.1/Matrix-M blood-stage malaria vaccine shows promise as a crucial secondary defence against malaria, complementing ...

A blood-stage malaria vaccine would not replace pre-erythrocytic vaccines, but provide a second line of defence.

Parasitology is the scientific discipline concerned with the study of the biology of parasites and parasitic diseases, including the distribution, biochemistry, physiology, molecular biology ...

The development of a blood-stage malaria vaccine would replace these vaccines as well provide a second line of defense. “There are 11 other malaria vaccines currently in Phase II development, ...

From the last malaria indicator survey, we found a prevalence of 22% among children less than 5 years old in the country.

Introduction: The global climatic changes pose a substantial threat to the well-being and productivity of both humans and animals. Methods: This study examined the impact of climate changes during ...

The global fight against malaria has taken a significant leap forward with the development of the first blood-stage malaria vaccine, RH5.1/Matrix-M. According to a report released by GlobalData, a ...

Olugbenga Mokuolu is a professor of paediatrics at the University of Ilorin Teaching Hospital and the current Strategic ...

Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases, the disease can progress to neurological ...

Department of Molecular, Cell and Systems Biology, University of California Riverside, Riverside, USA Stowers Institute for Medical Research, Kansas City, USA ...

This study introduces an important approach using selection linked integration (SLI) to generate Plasmodium falciparum lines expressing single, specific surface adhesins PfEMP1 variants, enabling ...